Register of
Medicinal Products

Product class: Medicinal product with marketing authorization
Medicinal product class: Veterinary medicine
Name of medicinal product: Avishield IB H120
Active substances:
Avian infectious bronchitis virus vaccine
Estonian, English, Latin
ATC code: QI01AD07
Dosage form: lyophilisate for oculonasal suspension/use in drinking water
Strength:  
Legal status for supply*: Subject to medicinal prescription
Summary of product characteristics (SPC):  (last updated March 23, 2020)
Package information leaflet (PIL): EST  (last updated March 23, 2020)
Labelling:  (last updated February 27, 2018)
Indication: For active immunisation of chickens (broiler and future layers/breeders) in order to reduce the detrimental effect resulting from the infection by avian infectious bronchitis virus, serotype Massachusetts on the ciliary activity, which may be manifested in respiratory clinical signs.. Onset of immunity: 3 weeks after vaccination Duration of immunity: 8 weeks after vaccination
Safety features: No
Marketing authorization holder: Genera d.d. 
Marketing authorization number: 2066 
Marketing authorization issued on: February 27, 2018 
Marketing authorization expires on: February 27, 2023 
Marketing authorization procedure type: Decentralised 
Assessment report:  (last updated February 27, 2018) 
Package code Name of medicinal product Dosage form Package Legal status Reimbursements Reference price Last imported Additional information
1730292  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  1000annust 10TK  Prescription         
1730304  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  2500annust 10TK  Prescription         
1730315  Avishield IB H120  lyophilisate for oculonasal suspension/use in drinking water  5000annust 10TK  Prescription         
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere